Northern Trust’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Northern Trust's TARS Position: Q3 2026 in Review
Northern Trust reduced its Tarsus Pharmaceuticals (TARS) stake by 2% in Q3 2026, selling an estimated $531K and leaving 378,966 shares worth $29.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.
Northern Trust first reported a position in TARS in Q4 2020 and has held it in 24 quarters since. 254 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Northern Trust held 378,966 shares of Tarsus Pharmaceuticals worth $29.8M as of Q3 2026.
- Northern Trust sold 7,645 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $531K.
- Tarsus Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #1504 holding.
- Northern Trust first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- 254 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.